Please Note: This trial is no longer enrolling new participants
A Phase 1/1b/2 Study of Cabozantinib in Combination With Selumetinib for Plexiform Neurofibroma in Adults and Adolescents With Neurofibromatosis Type 1
| Protocol No. | PHO-DOD-NF113 | Scope | National |
|---|---|---|---|
| Principal Investigator | Steven Rhodes | Treatment Type | Treatment |
| Age Group | Adults and Children | Phase | Phase I |
